Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1994 1
1995 5
1996 3
1997 2
1999 6
2000 11
2001 6
2002 7
2003 7
2004 2
2005 6
2006 9
2007 6
2008 4
2009 6
2010 9
2011 5
2012 6
2013 11
2014 13
2015 8
2016 8
2017 5
2018 4
2019 7
2020 6
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Results by year
Filters applied: . Clear all
Page 1
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Among authors: lambeau g. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, Brandt S, Kölling M, Wegmann U, Kiss B, Pál G, Gál P, Wüthrich RP, Wuhrer M, Beck LH, Salant DJ, Lambeau G, Kistler AD. Haddad G, et al. Among authors: lambeau g. J Clin Invest. 2021 Mar 1;131(5):e140453. doi: 10.1172/JCI140453. J Clin Invest. 2021. PMID: 33351779 Free PMC article.
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Seitz-Polski B, et al. Among authors: lambeau g. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24. Clin J Am Soc Nephrol. 2019. PMID: 31340979 Free PMC article. Clinical Trial.
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G. Tomas NM, et al. Among authors: lambeau g. N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13. N Engl J Med. 2014. PMID: 25394321 Free PMC article.
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation.
Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, Paré A, Rousseau M, Naika GS, Lévesque T, Laflamme C, Marcoux G, Lambeau G, Farndale RW, Pouliot M, Hamzeh-Cognasse H, Cognasse F, Garraud O, Nigrovic PA, Guderley H, Lacroix S, Thibault L, Semple JW, Gelb MH, Boilard E. Boudreau LH, et al. Among authors: lambeau g. Blood. 2014 Oct 2;124(14):2173-83. doi: 10.1182/blood-2014-05-573543. Epub 2014 Jul 31. Blood. 2014. PMID: 25082876 Free PMC article.
[Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B, Lambeau G, Esnault V. Seitz-Polski B, et al. Among authors: lambeau g. Nephrol Ther. 2017 Apr;13 Suppl 1:S75-S81. doi: 10.1016/j.nephro.2017.01.012. Nephrol Ther. 2017. PMID: 28577747 Review. French.
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.
Logt AV, Justino J, Vink CH, van den Brand J, Debiec H, Lambeau G, Wetzels JF. Logt AV, et al. Among authors: lambeau g. Kidney Int Rep. 2021 Apr 22;6(6):1677-1686. doi: 10.1016/j.ekir.2021.04.002. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169209 Free PMC article.
158 results